MONTEREY BIO ACQUISITION COR - COM (MTRY)

CUSIP: 61240F108

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / COM
Total 13F shares
8,544,230
Share change
-2,677,846
Total reported value
$87,454,463
Price per share
$10.12
Number of holders
34
Value change
-$26,786,238
Number of buys
12
Number of sells
19

Quarterly Holders Quick Answers

What is CUSIP 61240F108?
CUSIP 61240F108 identifies MTRY - MONTEREY BIO ACQUISITION COR - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MONTEREY BIO ACQUISITION COR - COM (MTRY) as of Q3 2022

As of 30 Sep 2022, MONTEREY BIO ACQUISITION COR - COM (MTRY) was held by 34 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,544,230 shares. The largest 10 holders included Periscope Capital Inc., Saba Capital Management, L.P., Karpus Management, Inc., MMCAP International Inc. SPC, BOOTHBAY FUND MANAGEMENT, LLC, ATW SPAC MANAGEMENT LLC, D. E. Shaw & Co., Inc., BERKLEY W R CORP, HGC Investment Management Inc., and Polar Asset Management Partners Inc.. This page lists 34 institutional shareholders reporting positions in this security for the Q3 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.